CMK Financial Statements (CHMK)

ЧМКsmart-lab.ru %   2018 2019 2020 2021 2022   LTM ?
Report date 13.07.2020 13.07.2020 30.04.2021 29.04.2022   29.08.2023
Currency RUB RUB RUB RUB RUB   RUB
Financial report URL  
Annual report URL  
Revenue, bln rub ? 123.8 112.4 113.6 176.3   78.6
Operating Income, bln rub 10.5 0.307 6.26 10.7   9.14
EBITDA, bln rub ? 14.0 3.90 9.78 14.3   10.8
Net profit, bln rub ? 6.80 3.90 -0.490 6.49   -14.3
OCF, bln rub ? 12.0 8.54 -3.76 0.045   10.9
CAPEX, bln rub ? 0.363 0.270 0.300 1.24   2.66
FCF, bln rub ? 10.00 4.97 -6.82 4.00   4.68
Ordinary share dividend yield, % 0.0% 0.0% 0.0% 0.0% 0.0%   0
Dividend payout ratio, % 0% 0% 0% 0%   0
OPEX, bln rub 11.4 10.8 12.1 17.7   28.1
Cost of production, bln rub 101.9 101.4 95.2 147.8   60.0
Amortization, bln rub   1.7
Employment expenses, bln rub 1.000 0.890 0.800 0.800  
Interest expenses, bln rub 6.06 8.98 8.95 10.0   4.94
Assets, bln rub 212.1 214.8 284.3 252.9 250.5   253.7
Net Assets, bln rub ? 33.1 37.0 36.5 43.1 55.9   41.7
Debt, bln rub 160.0 150.1 216.7 185.5 170.2   190.0
Cash, bln rub 0.200 0.470 0.022 4.73 0.360   0.620
Net debt, bln rub 159.8 149.6 216.7 180.8 169.8   189.4
Ordinary share price, rub 2 455 2 530 2 785 4 720 3 550   8 715
Number of ordinary shares, mln 3.16 3.16 3.16 3.16 3.16   3.16
Market cap, bln rub 7.76 8.00 8.81 14.9 11.2   27.6
EV, bln rub ? 167.6 157.6 225.5 195.7 181.1   216.9
Book value, bln rub 33.0 36.9 36.5 43.0 55.9   41.7
EPS, rub ? 2 151 1 233 -155.0 2 052 0.00   -4 507
FCF/share, rub 3 163 1 572 -2 156 1 265 0.00   1 480
BV/share, rub 10 439 11 673 11 528 13 610 17 680   13 178
EBITDA margin, % ? 11.3% 3.5% 8.6% 8.1%   13.7%
Net margin, % ? 5.5% 3.5% -0.4% 3.7%   -18.1%
FCF yield, % ? 128.8% 62.1% -77.4% 26.8% 0.0%   17.0%
ROE, % ? 20.6% 10.5% -1.3% 15.1% 0.0%   -34.2%
ROA, % ? 3.2% 1.8% -0.2% 2.6% 0.0%   -5.6%
P/E ? 1.14 2.05 -18.0 2.30   -1.93
P/FCF 0.78 1.61 -1.29 3.73   5.89
P/S ? 0.06 0.07 0.08 0.08   0.35
P/BV ? 0.24 0.22 0.24 0.35 0.20   0.66
EV/EBITDA ? 12.0 40.4 23.1 13.7   20.1
Debt/EBITDA 11.4 38.4 22.2 12.7   17.5
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00%   0
CAPEX/Revenue, % 0% 0% 0% 1%   3%
CMK shareholders